SLMBP:NASDAQSLM Corporation - Floating Rate Non-Cumulative Preferred Stock, Series B Analysis
Data as of 2026-06-13 - not real-time
$74.61
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock trades at $74.61, marginally below its 20‑day, 50‑day and 200‑day moving averages of roughly $74.9, indicating a neutral price stance. Technical signals are mixed: the MACD histogram is negative and the MACD line sits beneath its signal line, a bearish cue, while the RSI of 45.7 suggests no immediate overbought condition. Volume has been trending upward, providing some liquidity support despite the modest absolute daily volume. The dividend announcement of $1.4269 per share translates to an attractive ~7.9% yield, the highest among peers in the Credit Services space. However, the company’s financial profile raises red flags: a debt‑to‑equity ratio of over 250, total debt exceeding cash by more than $1 billion, and negative operating cash flow of $328 million. The trailing PE of 34.8 is more than double the industry average of 16.8, signaling that the market is pricing in strong growth expectations that the fundamentals do not currently substantiate. Furthermore, the payout ratio is reported as zero, reflecting uncertainty about the sustainability of the dividend given the cash‑flow shortfall.
With the Fear & Greed Index at an extreme‑greed level, investor sentiment is overly optimistic, which may mask underlying credit and regulatory vulnerabilities. The stock sits just above a calculated support of $73.45 and below a resistance near $75.08, leaving limited upside before hitting resistance. Given the high leverage and negative cash generation, any deterioration in loan performance or regulatory tightening could quickly erode equity value. While the dividend remains a short‑term attraction, the combination of overvaluation, weak cash fundamentals, and sector‑specific regulatory risk suggests caution. Overall, the current environment favors a defensive stance, with the dividend offering a modest buffer but not enough to offset the structural financial weaknesses. Investors should monitor cash‑flow trends, debt reduction progress, and potential regulatory developments before committing additional capital.
With the Fear & Greed Index at an extreme‑greed level, investor sentiment is overly optimistic, which may mask underlying credit and regulatory vulnerabilities. The stock sits just above a calculated support of $73.45 and below a resistance near $75.08, leaving limited upside before hitting resistance. Given the high leverage and negative cash generation, any deterioration in loan performance or regulatory tightening could quickly erode equity value. While the dividend remains a short‑term attraction, the combination of overvaluation, weak cash fundamentals, and sector‑specific regulatory risk suggests caution. Overall, the current environment favors a defensive stance, with the dividend offering a modest buffer but not enough to offset the structural financial weaknesses. Investors should monitor cash‑flow trends, debt reduction progress, and potential regulatory developments before committing additional capital.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- High dividend yield provides immediate income
- Increasing volume supports short‑term price stability
- Support level just below current price offers downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Overvalued PE relative to industry peers
- Negative operating cash flow and high leverage
- Potential regulatory scrutiny on loan origination
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Unsustainable dividend given cash‑flow deficits
- Debt‑to‑equity ratio exceeding 250%
- Elevated sector and regulatory risk could erode value
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin44.93%
P/E Ratio34.8
ROE30.93%
ROA2.57%
Debt/Equity253.08
P/B Ratio6.8
Op. Cash Flow$-328494016
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI45.7
Support$73.45
Resistance$75.08
MA 20$74.88
MA 50$74.72
MA 200$74.90
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
GradeOvervalued
TypeBlend
Dividend Yield7.94%
Risk Assessment
Beta0.02
Volatility4.71%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.